Expression of thymidine kinase mediated by a novel non-viral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells

World Journal of Gastroenterology : WJG
Ying WangQing Tang

Abstract

To investigate the killing efficiency of a recombinant plasmid containing a thymidine kinase (TK) domain insert driven by the vascular endothelial growth factor receptor 2 (VEGFR2) promoter (KDR) on vascular endothelial cells. The KDR-TK fragment was extracted from pBluescript II KDR-TK plasmid by enzymatic digestion with XhoI and SalI. The enhanced green fluorescence protein (EGFP) carrier was extracted from pEGFP by the same procedure. The KDR-TK was inserted into the pEGFP carrier to construct pEGFP-KDR-TK. Using ultrasound irradiation and microbubble, pEGFP-KDR-TK was transferred into human umbilical vein endothelial cells (HUVECs). The transient infection rate was estimated by green fluorescent protein (GFP) expression. Transfected HUVECs, non-transfected HUVECs, and HepG2 cells were cultured in the presence of different concentrations of ganciclovir (GCV), and the killing efficacy of HSV-TK/GCV was analyzed by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide (MTT) assay. The recombinant pEGFP-KDR-TK was successfully constructed by inserting the KDR-TK fragment into the pEGFP carrier. Transfected HUVECs showed cytoplasmic green fluorescence, and the transient transfection rate was about 20.3%. Pools of G418-...Continue Reading

References

May 1, 1976·Scientific American·J Folkman
Feb 21, 1990·Journal of the National Cancer Institute·F L Moolten, J M Wells
Sep 10, 1996·Human Gene Therapy·G RossB R Smith
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·C BeltingerK M Debatin
Aug 16, 2000·Ultrasound in Medicine & Biology·S KochN G Rainov
Aug 30, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T U KrohneL Mohr
Oct 11, 2001·Molecular Genetics and Metabolism·Q R ChenA J Mixson
Apr 18, 2002·Cancer Gene Therapy·Christian BeltingerKlaus-Michael Debatin
Dec 20, 2002·Human Gene Therapy·Yo-ichi YamashitaKeizo Sugimachi
Nov 5, 2003·Ultrasound in Medicine & Biology·Allan LawrieChristopher M Newman
Dec 31, 2003·Ultrasound in Medicine & Biology·Jonathan P ChristiansenJonathan R Lindner
Dec 14, 2004·Acta Biochimica Et Biophysica Sinica·Dong-Ping GuoXiao-Rong Li
Dec 24, 2005·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Hui-Xiong XuJin-Yu Liang
Mar 18, 2006·Thrombosis and Haemostasis·Andrew D Blann
Sep 28, 2006·Journal of Biochemistry and Molecular Biology·Masabumi Shibuya
Dec 15, 2006·World Journal of Gastroenterology : WJG·Fang NieMing-De Lu

❮ Previous
Next ❯

Citations

Mar 30, 2010·Acta Pharmacologica Sinica·Hong YangHirokazu Miyoshi
Feb 22, 2011·Virology Journal·Weiguo JiaGuowei Che
Feb 6, 2010·Ultrasound in Medicine & Biology·Cheng-Huang SuHung-I Yeh
Dec 17, 2010·World Journal of Radiology·Hui-Xiong Xu
Jun 27, 2019·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Christopher LauVinay Duddalwar

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.